ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition

Overview of attention for article published in BMC Cancer, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,611 followers.

🥊 Attacking a breast-cancer initiating target (Prolactin Receptor) with a novel warhead => https://t.co/rHovx2T29Q https://t.co/CgRuGPzLqd

New article: ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition https://t.co/MR1dS4Fop2 #breastcancer #oncology https://t.co/Y93Rg9qp5a

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.